Search

for
Search:

Did you mean Beta-Blockers?

Glossary Beta-Blockers

Beta-blockers are a class of medications primarily used to manage cardiovascular conditions by blocking the effects of adrenaline on beta-adrenergic receptors. Their relevance to hair loss lies in their potential side effects, which can include hair thinning or shedding in some individuals. This is particularly notable in patients who may be genetically predisposed to hair loss, as beta-blockers can exacerbate underlying conditions like androgenetic alopecia. Key distinguishing characteristics of beta-blockers include their ability to lower heart rate and blood pressure, which can influence overall health and potentially impact hair growth cycles.

Related Terms

Sort by

Research

30 / 1000+ results

research Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol.

3 citations , February 1985 in “PubMed”

This report describes a case in which the use of the beta-blocker nadolol was associated with infiltrative dermatitis and significant alopecia, which resolved and resulted in total hair regrowth after discontinuation of the drug.

research CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS

22 citations , April 1985 in “Australasian Journal of Dermatology”

This review discusses the uncommon but potentially serious cutaneous reactions to beta-adrenergic blockers and the uncertain pathogenesis, with no new clinical results reported.

research Profound bradycardia after addition of diltiazem to a beta blocker.

9 citations , March 1989 in “The BMJ”

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

research DRUG‐ASSOCIATED ALOPECIA

63 citations , March 1995 in “International Journal of Dermatology”

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Drugs and Hair Loss: Mechanisms and Clinical Implications

research Drugs and Hair Loss

54 citations , September 2012 in “Dermatologic Clinics”

This review discusses possible medication-induced hair loss and the need to exclude other confounding factors like stress and illness; it reports no new clinical findings and emphasizes careful assessment before attributing hair loss to medications.

research Psychotropic Medication and Drug-Related Alopecia

30 citations , May 1991 in “Psychosomatics”

This review examines alopecia as a side effect of psychotropic medications, noting that it is typically reversible after stopping the drug, but it reports no new results.

research Minoxidil for Control of Acute Blood Pressure Elevation in Chronically Hypertensive Children

23 citations , November 1986 in “Pediatrics”

Minoxidil, when used with a diuretic and β-blocking agent, can safely lower blood pressure in most children with severe hypertension due to kidney disease, with minimal side effects.

research Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations

16 citations , December 2011 in “Actas Dermo-Sifiliográficas”

This review discusses the current understanding of propranolol's use in treating infantile hemangiomas, covering its indications, effectiveness, side effects, and ongoing clinical trials, without presenting new clinical results.

research INDUCTION OF PSORIASIFORM CHANGES IN GUINEA PIG SKIN BY PROPRANOLOL

15 citations , November 1994 in “International Journal of Dermatology”

This study found that while the combination of oral propranolol and intradermal injections in guinea pigs led to psoriasiform changes, it did not fully mimic psoriasis.

research A falling out following minoxidil: Telogen effluvium

9 citations , January 1987 in “Journal of The American Academy of Dermatology”

This study supports the idea that angiolymphoid hyperplasia with eosinophilia is an inflammatory process linked to immunologic injuries rather than a proliferative condition.

research Long-term experiences with minoxidil in combination treatment of severe arterial hypertension.

6 citations , January 1977 in “PubMed”

This study found that minoxidil, used with beta-blockers and thiazides, effectively reduced blood pressure in patients with severe hypertension, although it required careful management of side effects like sodium retention and increased hair growth.

research Metoprolol and alopecia.

5 citations , December 1981 in “PubMed”

This study describes a case where metoprolol was associated with reversible telogen effluvium, suggesting a similar mechanism of alopecia as seen with other beta-adrenoceptor antagonists.

research No association between low-dose oral minoxidil and tachycardia in a large retrospective cohort study of patients with non-scarring alopecia

4 citations , August 2025 in “Journal of the American Academy of Dermatology”

Low-dose oral minoxidil does not cause tachycardia in hair loss patients.

Pill Organizers and Cutters: Risks and Restrictions on Use

research Organizadores e cortadores de comprimidos: riscos e restrições ao uso

4 citations , February 2013 in “Revista De Saude Publica”

This article examines the public health risks and benefits of pill organizers and cutters, concluding that healthcare professionals should guide their use to prevent potential medication stability and efficacy issues.

research [Drug induced alopecia].

4 citations , May 1999 in “PubMed”

This article reviews various drugs reported to cause alopecia, including cytostatics and anticoagulants, but does not present new research results; it suggests that drug-related hair loss can be difficult to prove.

research Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension

3 citations , January 2017 in “Journal of cardiovascular pharmacology”

This article discusses the challenges in hypertension management, emphasizing the need to reconsider the use of minoxidil and address excess dietary sodium and arteriolar hypertrophy, but reports no new clinical results.

research FFA Patient Profile Analysis Based on the Authors’ Observations and a Review of the Literature—An Original Survey

1 citations , June 2025 in “Journal of Clinical Medicine”

This study reported that frontal fibrosing alopecia predominantly affects postmenopausal women and identified potential risk factors like frequent β-blocker use and sunscreen application, indicating the need for further research.

research Drug Repurposing in Dermatology: Molecular Biology and Omics Approach

1 citations , August 2020 in “IntechOpen eBooks”

This review highlights drug repositioning strategies for discovering new treatments for skin conditions and reports no new clinical results, emphasizing the integration of systematic methods with advances in molecular biology and omics.

research Reply

1 citations , January 1987 in “Journal of The American Academy of Dermatology”

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

research Investigating drug induced alopecia

1 citations , February 1993 in “Nursing Standard”

This article highlights that nurses may not be sufficiently aware of the potential for various drug groups, beyond cytotoxic drugs, to cause alopecia, and emphasizes the importance of early recognition of this side effect.

Catecholaminergic Neurons Enhance Fibroblast Osteogenic Activity in Keloid

research Catecholaminergic neurons boost fibroblast osteogenic activity in keloid

May 2026 in “Nature Communications”

In this study, researchers identified that keloid fibroblasts respond to neurotransmitters from catecholaminergic nerves by producing bone matrix proteins, mediated by β1-adrenergic receptor activation, leading to fibro-osseous reprogramming; blocking this signaling in a rodent model prevented the development of keloid-like pathology.

research Telogen Effluvium and Anesthesia Considerations: A Case Report

July 2025 in “Cureus”

This case report describes a 61-year-old woman with telogen effluvium, highlighting her concerns about exacerbated hair loss after surgery and aims to explore anesthesia techniques that might reduce hair shedding in such patients.

$Total Thyroidectomy in Refractory Thyrotoxicosis$

research TOTAL THYROIDECTOMY IN REFRACTORY THYROTOXICOSIS

March 2016 in “Indian Journal Of Applied Research”

This report presents a case of refractory thyrotoxicosis where the patient required a total thyroidectomy after resistance to conventional treatments including antithyroid drugs and radioactive iodine.

Severe Sarcoidosis: A Retrospective Study of 86 Cases

research Sarcoïdose grave

January 2014 in “Revue des Maladies Respiratoires”

This study confirmed significant and dramatic ophthalmic and mucocutaneous sequelae from Stevens-Johnson and Lyell syndromes in Morocco, affecting the social and professional integration of mostly young patients.

research Metoprolol

June 1982 in “Reactions (Auckland)”

Metoprolol and propranolol may cause hair loss.

research Medical management of benign prostatic hyperplasia

March 2024 in “Cleveland Clinic journal of medicine”

This review details contemporary medical management options for benign prostatic hyperplasia, highlighting the expanding role of phosphodiesterase-5 inhibitors and beta-3 agonists, but reports no new clinical findings.

research Alopecia Induced by Timolol Eye-drops

8 citations , August 2016 in “Acta dermato-venereologica”

Timolol eye-drops can cause hair loss.

Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

research Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

35 citations , May 2020 in “Frontiers in Pharmacology”

This review provides a comprehensive overview of the mechanisms, efficacy, and adverse reactions of drugs commonly used for treating benign prostatic hyperplasia but reports no new clinical results.

research 4-aminopyridine promotes accelerated skin wound healing via neurogenic-mediator expression

November 2021 in “bioRxiv (Cold Spring Harbor Laboratory)”

This study found that 4-aminopyridine, a potassium channel blocker, greatly improves skin wound healing by accelerating wound closure, enhancing tissue regeneration, and promoting hair follicle neogenesis.

research Anti-anginal and beta-adrenoceptor blocking drugs

January 1983 in “Side effects of drugs annual”

This chapter reviews adverse effects of anti-anginal and beta-blocker drugs, stating that starting a beta-blocker may temporarily affect driving ability, but it reports no new clinical findings.